Advertisement

Topics

Latest "Sinclair Pharma" News Stories

17:37 EDT 24th September 2018 | BioPortfolio

Here are the most relevant search results for "Sinclair Pharma" found in our extensive news archives from over 250 global news sources.

More Information about Sinclair Pharma on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Sinclair Pharma for you to read. Along with our medical data and news we also list Sinclair Pharma Clinical Trials, which are updated daily. BioPortfolio also has a large database of Sinclair Pharma Companies for you to search.

Showing "Sinclair Pharma" News Articles 1–25 of 7,500+

Relevant

SINCLAIR BROADCAST SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF ...

NEW ORLEANS, Sept. 7, 2018 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 9, 2018 to file lead Read more...


SINCLAIR BROADCAST SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK FOTI, LLC ...

NEW ORLEANS, Aug. 17, 2018 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., Read more...

Deals and M&As this week: LEO Pharma, Valeo Pharma, Allergan

LEO Pharma and MorphoSys have formed a strategic partnership to develop peptide-derived therapeutics. LEO Pharma will select lead molecules using...Read More... The post Deals and M&As this week: LEO Pharma, Valeo Pharma, Allergan appeared first on Pharmaceutical Technology.


More pharma cos sign MoUs with MADC to set up bulk drugs park in MIHAN, Nagpur

Following execution of MoUs with pharma companies─ Centaur, SG Pharma, Arco Lifesciences, BDH Pharma, Maharashtra Airport Development Company Ltd (MADC) has recently inked MoUs with pharma companies

Probably Relevant

Deals this week: Zealand Pharma, Fulcrum Therapeutics, Forendo Pharma

Zealand Pharma has sold its future royalty streams and potential commercial milestones for Soliqua® 100/33/Suliqua® and Lyxumia®/Adlyxin® to Royalty Pharma...Read More... The post Deals this week: Zealand Pharma, Fulcrum Therapeutics, Forendo Pharma appeared first on Drug Development Technology.

CR Pharma to Acquire Jiangzhong Pharma for $667 Million

China Resources Pharma will pay $667 million to acquire all the outstanding shares of Jiangzhong Pharma, a listed company. Three weeks ago, CR Pharma announced plans to acquire a stake in the parent company, Jiangzhong Group, for $613 million, which will, when added to its current holdings, give CR Pharma majority control of Jiangzhong Group. Jiangzhong Group, the parent, owns a 43% stake in Jiang...

#jobs #lifescience Accountant – Biotech / Pharma (Up to $70K)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Accountant – Biotech / Pharma (Up to $70K) .MA-Boston, Publicly Traded Bio-Tech/Pharma Company is looking for a talented Staff Accountant to join their corporate headquarters located just west … Continue reading → Cet article #jobs #lifescience Accountant ...

Celtic Pharma: Attracting Big Pharma with experience and raising US$ 750M

In this interview, filmed at PharmaTelevision’s Oxford Studios, Dr Fintan Walton speaks with Stephen Parker, Partner at Celtic Pharma, a source of private equity and venture capital created in 2004. They discuss: • the drug assets acquired from companies including Xenova, IDEA and Inspire • Celtic Pharma’s Funds, their investors and their aims to raise US$750 M • attracting Big Pharma, ...

Pharma Integrates 2017: A New Value Proposition for Pharma

London, UK, 22nd November 2017 / Sciad Newswire / Further insights from the podium as the Pharma Integrates panellists tackle changing product and technological developments and a new patient-payer value chain, and ponder whether the future of pharma is in the hands of drug manufacturing companies

Tetra Bio-Pharma Inc.: Tetra Bio-Pharma Completes Acquisition of Remaining 20% Interest in PhytoPain Pharma Inc.

OTTAWA, ONTARIO -- (Marketwired) -- 03/19/18 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") (TSX VENTURE: TBP)(OTCQB: TBPMF), today announced the completion of the previously announced acq...

Verona Pharma plc: Verona Pharma to Present at 2018 Wedbush PacGrow Healthcare Conference

LONDON, July 24, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovati...

FSD Pharma: Jetzt noch auf den Cannabis-Hype aufspringen

FSD Pharma ist das Mutterunternehmen der FC Pharma Inc, welche ein lizensierter Marihuana Hersteller aus Kanada ist. Das Unternehmen aus Ontario hat sich die Zucht, Verarbeitung, Herstellung, Extra...

Opiant Pharma stock nearly doubles on deal by Emergent Bio to buy Adapt Pharma

Acquisition of Adapt Pharma underscores potential for companies in the opioid overdose market

Why pharma engagement on twitter matters!

The fact that thousands of stakeholders chose to follow pharma accounts on twitter deserves our attention. It says that there are people out there genuinely interested in what pharma has ...

ANI Pharma Acquires WellSpring Pharma For $18 Mln

WASHINGTON (dpa-AFX) - While reporting its second-quarter financial results today, ANI Pharmaceuticals Inc. (ANIP) said it has acquired WellSpring Pharma Services Inc. for $18 million in cash, to ...

IRW-News: FSD Pharma Inc.: FSD Pharma gibt Börsengang an der Börse Frankfurt bekannt

IRW-PRESS: FSD Pharma Inc.: FSD Pharma gibt Börsengang an der Börse Frankfurt bekannt FSD Pharma gibt Börsengang an der Börse Frankfurt bekannt TORONTO, 14. August 2018 / FSD Pharma Inc. (FSD Phar...

FSD Pharma Aktie: FSD Pharma will in den NASDAQ!

Über kurz oder lang will FSD Pharma am amerikanischen Aktienindex NASDAQ gelistet werden. Dabei handelt es sich um nicht weniger als die größte elektronische Börse des Landes. Ermöglichen soll die ...

Dow Pharma Solutions showcases pharma portfolio at CPhI NA

Dow Pharma Solutions – a division of the DowDuPont Specialty Products Division – will showcase its portfolio of pharma solutions at CPhI North America, taking place this week in Philadelphia

Pfenex, NT Pharma ink development & license pact for Pfenex's PF708 therapeutic equivalent candidate to Forteo

Pfenex Inc. and China NT Pharma Group Company Limited (NT Pharma) announced an agreement under which Pfenex granted NT Pharma non─exclusive development and exclusive commercialization rights to PF708

Verona Pharma plc: Block Listing Update

LONDON, May 31, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovativ...

IRW-News: Creso Pharma Limited: Creso Pharma Update 2. Quartal (Juni)

IRW-PRESS: Creso Pharma Limited: Creso Pharma Update 2. Quartal (Juni) Meldung der ASX 31. Juli 2018 Creso Pharma - Update 2. Quartal (Juni) Höhepunkte: - Creso investiert weiterhin stark in kanad...

#jobs #lifescience Pharma/Biotech Validation Specialist IV

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Pharma/Biotech Validation Specialist IV .MA-Marlborough, We are seeking a candidate for a high priority role within a highly visible project for a global industry leader located in MA. … Continue reading → Cet article #jobs #lifescience Pharma/Biotech Validation Sp...

Bayer Schering Pharma: Michael Yeomans on Growth in Pharma and New Deals

In this episode of PharmaTelevision News Review, Fintan Walton talks with Michael Yeomans, VP Business Development & Licensing at Bayer Schering Pharma*. Filmed at BioChicago 2010 in Chicago, USA, they discuss: • Strategy after merger and key focus areas • Michael Yeomans' role at Bayer Schering Pharma • Biggest growth in speciality pharma areas • Clinical stage deals vs research stage co...

Natco Pharma net zooms by 93% to Rs.181 cr in Q1

Natco Pharma, a Rs.2,200 crore pharma major from Telangana, has posted impressive financial performance during the first quarter ended June 2018 and its consolidated net profit went up by 93.3 per cent to Rs.181.1 crore

FSD Pharma (CSE: $HUGE.C) secures exclusive rights in Canada for line of proprietary products and premium access to #cannabinoid science research platform in Israel

TORONTO - June 6, 2018 (Investorideas.com Newswire) FSD Pharma Inc. (the "Company") (CSE: HUGE), is pleased to announce that its wholly - owned subsidiary FV Pharma Inc ("FV Pharma") have entered into a strategic alliance with SciCann Therapeutics Inc. ("SciCann") by executing a binding Memorandum of Understanding (the "MOU") dated May 28, 2018


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks